Go to JCI Insight
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
  • Clinical Research and Public Health
  • Current issue
  • Past issues
  • By specialty
    • COVID-19
    • Cardiology
    • Gastroenterology
    • Immunology
    • Metabolism
    • Nephrology
    • Neuroscience
    • Oncology
    • Pulmonology
    • Vascular biology
    • All ...
  • Videos
    • Conversations with Giants in Medicine
    • Video Abstracts
  • Reviews
    • View all reviews ...
    • Complement Biology and Therapeutics (May 2025)
    • Evolving insights into MASLD and MASH pathogenesis and treatment (Apr 2025)
    • Microbiome in Health and Disease (Feb 2025)
    • Substance Use Disorders (Oct 2024)
    • Clonal Hematopoiesis (Oct 2024)
    • Sex Differences in Medicine (Sep 2024)
    • Vascular Malformations (Apr 2024)
    • View all review series ...
  • Viewpoint
  • Collections
    • In-Press Preview
    • Clinical Research and Public Health
    • Research Letters
    • Letters to the Editor
    • Editorials
    • Commentaries
    • Editor's notes
    • Reviews
    • Viewpoints
    • 100th anniversary
    • Top read articles

  • Current issue
  • Past issues
  • Specialties
  • Reviews
  • Review series
  • Conversations with Giants in Medicine
  • Video Abstracts
  • In-Press Preview
  • Clinical Research and Public Health
  • Research Letters
  • Letters to the Editor
  • Editorials
  • Commentaries
  • Editor's notes
  • Reviews
  • Viewpoints
  • 100th anniversary
  • Top read articles
  • About
  • Editors
  • Consulting Editors
  • For authors
  • Publication ethics
  • Publication alerts by email
  • Advertising
  • Job board
  • Contact
EPHB4 kinase–inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis
Silvia Martin-Almedina, … , Taija Makinen, Pia Ostergaard
Silvia Martin-Almedina, … , Taija Makinen, Pia Ostergaard
Published July 11, 2016
Citation Information: J Clin Invest. 2016;126(8):3080-3088. https://doi.org/10.1172/JCI85794.
View: Text | PDF
Research Article Genetics

EPHB4 kinase–inactivating mutations cause autosomal dominant lymphatic-related hydrops fetalis

  • Text
  • PDF
Abstract

Hydrops fetalis describes fluid accumulation in at least 2 fetal compartments, including abdominal cavities, pleura, and pericardium, or in body tissue. The majority of hydrops fetalis cases are nonimmune conditions that present with generalized edema of the fetus, and approximately 15% of these nonimmune cases result from a lymphatic abnormality. Here, we have identified an autosomal dominant, inherited form of lymphatic-related (nonimmune) hydrops fetalis (LRHF). Independent exome sequencing projects on 2 families with a history of in utero and neonatal deaths associated with nonimmune hydrops fetalis uncovered 2 heterozygous missense variants in the gene encoding Eph receptor B4 (EPHB4). Biochemical analysis determined that the mutant EPHB4 proteins are devoid of tyrosine kinase activity, indicating that loss of EPHB4 signaling contributes to LRHF pathogenesis. Further, inactivation of Ephb4 in lymphatic endothelial cells of developing mouse embryos led to defective lymphovenous valve formation and consequent subcutaneous edema. Together, these findings identify EPHB4 as a critical regulator of early lymphatic vascular development and demonstrate that mutations in the gene can cause an autosomal dominant form of LRHF that is associated with a high mortality rate.

Authors

Silvia Martin-Almedina, Ines Martinez-Corral, Rita Holdhus, Andres Vicente, Elisavet Fotiou, Shin Lin, Kjell Petersen, Michael A. Simpson, Alexander Hoischen, Christian Gilissen, Heather Jeffery, Giles Atton, Christina Karapouliou, Glen Brice, Kristiana Gordon, John W. Wiseman, Marianne Wedin, Stanley G. Rockson, Steve Jeffery, Peter S. Mortimer, Michael P. Snyder, Siren Berland, Sahar Mansour, Taija Makinen, Pia Ostergaard

×

Figure 6

Early embryonic deletion of Ephb4 leads to a failure of LVV formation.

Options: View larger image (or click on image) Download as PowerPoint
Early embryonic deletion of Ephb4 leads to a failure of LVV formation.
(...
(A) Schematic representation of LVV formation. CV, cardinal vein; A, artery. Adapted with permission from Developmental Biology (ref. 16; Creative Commons user license available at http://www.sciencedirect.com/science/article/pii/S0012160615301032). (B) Whole-mount immunofluorescence of a transverse section of E13.5 Ephb4+/+ Prox1-CreERT2 R26-mTmG embryo for indicated proteins. GFP shows efficient Cre-mediated recombination in the LVV that extends to the lumen of the cardinal vein (arrow). (C) Whole-mount immunofluorescence of E13.5 LVVs showing extension of the valve leaflets to the lumen of the cardinal vein (arrow) in control (upper panel, n = 11 out of 11) but not in Ephb4 mutant (Ephb4 mut) embryo (lower panel, n = 9 out of 13). (D) Quantification of LVV morphology in control and Ephb4 mutant embryos. Normal, elongated leaflets; abnormal, no leaflets. P value determined by Fisher’s exact test. Scale bars: 50 μm (B); 25 μm (C).

Copyright © 2025 American Society for Clinical Investigation
ISSN: 0021-9738 (print), 1558-8238 (online)

Sign up for email alerts